Law Office of Jean Sutton Martin, PLLCLaw Office of Jean Sutton Martin, PLLC
contact Menu
Free Consultations: 800-678-6612

Drug Injury Archives

Second Jury Finds Janssen Failed To Warn Of Risperdal Risks

This year, two juries in Philadelphia have found that Johnson & Johnson division, Janssen, failed to warn about the risk of male breast growth associated with the use of the drug, Risperdal.  In February, a jury rendered a $2.5 million verdict for a young male who had developed size 44DD breasts after using Risperdal for behavioral issues stemming from autism.  In March, in the second trial on this issue, a jury decided that the manufacturer failed to properly warn of the risk of gynecomastia but ultimately ruled that Risperdal did not cause that plaintiff's breast growth.

Jury Finds Risperdal Linked To Gynecomastia In Young Man

Earlier this year, a Philadelphia jury awarded $2.5 million for a young man who had developed gynecomastia as a result of taking Risperdal.  The jury found that Janssen, a subsidiary of Johnson & Johnson, failed to adequately warn of the risk of gynecomastia -  a condition which causes men and boys to develop breasts.

Some over-the-counter products could possibly be defective drugs

Many North Carolina residents rely on various types of over-the-counter drugs to help get them through the physical and mental stresses they incur each day. Some of the most common types of drugs and medications that are readily sold at pharmacies and convenience stores come with a risk of side effects. The level for potential harm can sometimes increase when an individual is taking multiple drugs or medications within a close time frame of each other. Unfortunately, dangerous and defective drugs can result in devastating and even fatal consequences to an individual's health.

Medication Errors Happen More Often Than You Think

There was a great article in Forbes regarding the prevalence of medication errors in hospitals. Whether it happens in-patient at a hospital or through your local walk-in pharmacy, medication errors are on the rise and cause serious consequences.

Low T Therapy May Mean High Risk For Heart Attack & Strokes

Men using testosterone supplement therapies for "Low T" need to be aware of a potential increased risk for heart attack, strokes and blood clots due to these defective drugs. A recent study shows that men using prescription testosterone supplements have an increased risk of suffering heart attacks, strokes and blood clots. In the men studied, the risk of heart attack doubled in the 90 days after beginning use of Low T therapies. This study comes on the heels of another study published in the Journal of the American Medical Association, finding a 29% increase in stroke, heart attack and death in men undergoing testosterone therapy. In 2009, the Journal of New England Medicine reported that a federally-funded research study on testosterone gels was stopped after researchers noticed that some of the participants were suffering heart attacks and other heart-related problems.

Does Mirena Cause Intracranial Hypertension aka Pseudotumor Cerebri (PTC)?

Pseudotumor cerebri (PTC for short) is a debilitating condition that arises when fluid accumulates in the brain creating pressure in the skull. PTC is also known as intracranial hypertension. The increased pressue in the skull is known to cause severe migraine-like headaches. Also, the pressure can cause the optic nerves to swell (papilledema) leading to blurred or double vision or even loss of vision.

Safety Alert - Testosterone Drugs May Increase Risk of Heart Attack

Studies regarding "Low T" testosterone supplement therapies are grabbing everyone's attention, especially the FDA. These studies are indicating that men who use prescription testosterone drugs are at an increased risk for heart attack, stroke and death. The scientific evidence in these reports is so strong that the FDA has announced that it is launching its own investigation into the safety of the potentially dangerous Low T therapies.

Does Zofran Cause Birth Defects?

zofran.jpgThe Law Office of Jean Sutton Martin PLLC is investigating claims of mothers who were prescribed the medication Zofran (ondansetron) for nausea during their first trimester of pregnancy and delivered children with birth defects. Zofran was never tested or approved for use by pregnant women, but the manufacturer GlasoSmithKline pushed the off-label use for morning sickness.

Topamax Maker Failed To Adequately Warn Of Birth Defect Risk

There are several drugs on the market that when ingested by a pregnant woman exposes the fetus to great risk of birth defects.  A jury in Philadelphia  found that Janssen Pharmaceuticals, the manufacturer of Topamax, failed to adequately warn consumers and their doctors of the risk of birth defects associated with use of the migraine medication. The jury awarded $3 million to the parents of a child born with a cleft palate and bilateral cleft lip.

Begin a Free Consultation

Contact us now to begin a free consultation

Bold labels are required.

Contact Information
disclaimer.

The use of the Internet or this form for communication with the firm or any individual member of the firm does not establish an attorney-client relationship. Confidential or time-sensitive information should not be sent through this form.

close

Privacy Policy

Law Office of Jean Sutton Martin, PLLC 2018 Eastwood Road Suite 225 Wilmington, NC 28403 Toll Free: 800-678-6612 Wilmington Law Office Map